Friday, November 21, 2008

You are here: Home > Clinical Trials & Research > Gastrointestional Cancer

Gastrointestional Cancer

ACOSOG Z6041 Lead group: ACOSOG
A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for uT2uN0 Rectal Cancer
CALGB 80101 Lead group: CALGB
Phase III Intergroup Trial of Adjuvant Chemoradiation After Resection of Gastric or Gastroesophageal Adenocarcinoma
E5202 Lead group: ECOG
A Randomized Phase III Study Comparing 5-FU Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
E5204 Lead group: ECOG
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation
N0147 Lead group: NCCTG
A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or without Cetuximab (C225) after Curative Resection for Patients with Stage III Colon Cancer
NSABP-R-04 Lead Group: NSABP
A Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with or without Oxaliplatin with Preoperative Radiation Therapy and Continuous Intravenous Infusion of 5-Fluorouracil with or without Oxaliplatin in the Treatment of Patients with Operable Carcinoma of the Rectum
A6181104  
A randomized, Phase 2b study of sunitinib plus oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) versus bevacizumab plus FOLFOX as first-line treatment in patients with metastatic colorectal cancer.
A4061034  
A Randomized, Phase 2 Study of FOLFOX or FOLFIRI with AG-013736 or Bevacizumab in Patients with Metastatic Colorectal Cancer After Failure of an Irinotecan or Oxaliplatin-Containing First-Line Regimen.

We participate in many NCI sponsored trials. Please feel free to contact Leann Ross at (304) 399-6617 or leann.ross@chhi.org or Barbara Payne at (304) 399-6637.

For more information about the clinical trials listed please go to http://www.clinicaltrials.gov/.

Page last updated: 11/12/2008  |  Recommend this page  |  Printer friendly version